Eupraxia Pharmaceuticals Inc. (EPRX) vs Sagimet Biosciences Inc. (SGMT)

Eupraxia Pharmaceuticals Inc. and Sagimet Biosciences Inc. are both Biotechnology companies. Eupraxia Pharmaceuticals Inc. and Sagimet Biosciences Inc. are of similar size ($561.1M and $537.8M). Across the 10 metrics below, Sagimet Biosciences Inc. leads on 7 and Eupraxia Pharmaceuticals Inc. on 3.

Valuation

Metric EPRX SGMT Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 5.30 1.92 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (12.73%) (13.85%) (28.84%)
Free cash flow yield (7.21%) (8.50%) (23.03%)

Profitability

Metric EPRX SGMT Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (117.82%) (24.37%) (57.72%)
Return on assets (64.44%) (23.49%) (49.22%)
Return on invested capital 0.00% (205.24%) 0.00%

Growth

Metric EPRX SGMT Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (35.53%) (8.97%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EPRX SGMT Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 16.00 45.02 4.73
Net debt to EBITDA 2.11 1.98 0.96

Dividend

Metric EPRX SGMT Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric EPRX SGMT Biotechnology median
Market cap 537.83m 561.10m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack